• Donate
  • Contact
  • Home
  • About Us
    • Portraits of Pompe
    • Our Partners
  • About Pompe
    • Diagnosing Pompe
    • Talk Pompe
    • Webinars
  • Blog
  • Resources
    • Pompe – How to
    • Links
    • Connections
  • Home
  • About Us
    • Portraits of Pompe
    • Our Partners
  • About Pompe Disease
  • Diagnosing Pompe Disease
    • Talk Pompe
    • Webinars
  • Blog
  • Resources
    • Pompe – How to
    • Links
    • Connections
  • Donate
  • Contact
Audentes Therapeutics Update on Pompe and Other Programs

Audentes Therapeutics Update on Pompe and Other Programs

by Brad Crittenden | May 7, 2019 | News

Audentes Therapeutics provides updates on their AAV-based genetic medicine program for serious rare neuromuscular diseases.

Recent Posts

  • Nexviazyme Meets All Endpoints in Phase 3 Study for Infantile-Onset Pompe Disease
  • First Participant Dosed in Phase 1/2 Gene Therapy Trial for Late-Onset Pompe Disease
  • First Patients Enrolled in Phase 2 Trial of SRT for Late-Onset Pompe Disease
  • Aro Biotherapeutics reports positive phase 1b results for ABX1100
  • 2025 Pompe Empowerment Workshop : Vancouver
  • Terms
  • Privacy
Copyright © 2006 -2026 Canadian Association of Pompe
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.